Betrouni N, Colin P, Puech P, Villers A, Mordon S
Annu Int Conf IEEE Eng Med Biol Soc. 2013;2013:370-3. doi: 10.1109/EMBC.2013.6609514.
This study describes a multimodality images based platform to drive photodynamic therapies of prostate cancer using WST 11 TOOKAD Soluble drug. The platform integrates a pre-treatment planning tool based on magnetic resonance imaging and a per-treatment guidance tool based on transrectal ultrasound images. Evaluation of the platform on clinical data showed that prediction of the therapy outcome was possible with an accuracy of 90 %.
本研究描述了一种基于多模态图像的平台，该平台使用WST 11 TOOKAD可溶性药物来驱动前列腺癌的光动力疗法。该平台集成了一个基于磁共振成像的治疗前规划工具和一个基于经直肠超声图像的治疗过程引导工具。基于临床数据对该平台进行的评估表明，能够以90%的准确率预测治疗结果。
